Shanghai Medicilon Inc
SSE:688202
Operating Income
Forecast
Operating Income Estimate
Shanghai Medicilon Inc
For the last 5 years the compound annual growth rate for Shanghai Medicilon Inc's operating income is 48%. The projected CAGR for the next 2 years is -42%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Shanghai Medicilon Inc's stock price target?
Not Available
Shanghai Medicilon Inc doesn't have any price targets made by Wall Street professionals.
What is Shanghai Medicilon Inc's Revenue forecast?
Projected CAGR
14%
For the last 5 years the compound annual growth rate for Shanghai Medicilon Inc's revenue is 46%. The projected CAGR for the next 3 years is 14%.
What is Shanghai Medicilon Inc's Operating Income forecast?
Projected CAGR
-42%
For the last 5 years the compound annual growth rate for Shanghai Medicilon Inc's operating income is 48%. The projected CAGR for the next 2 years is -42%.
What is Shanghai Medicilon Inc's Net Income forecast?
Projected CAGR
-4%
For the last 5 years the compound annual growth rate for Shanghai Medicilon Inc's net income is 52%. The projected CAGR for the next 3 years is -4%.